Newsletter
Every new paper in this field, in your inbox.
In a phase II study, researchers explored the efficacy of intraperitoneal paclitaxel combined with S-1 and cisplatin for gastric cancer with peritoneal metastasis. Among 53 patients, the treatment achieved a 73.6% 1-year overall survival rate, meeting the primary endpoint. The median survival time was 19.4…
In a comprehensive study of 3,684 patients undergoing percutaneous transesophageal gastro-tubing (PTEG) in Japan, researchers found a mere 1.3% complication rate. PTEG served diverse purposes, with 1,455 cases for decompression and 2,193 for feeding. Notably, complications led to minimal invasive treatments, predominantly red blood cell…
Researchers unveil a tech-savvy twist to esophageal cancer diagnosis, sidelining the subjective pink-color sign's (PCS) hiccups. Testing the V' variable solo, results hit 73.91% sensitivity, lagging behind human eyes. But, combining V' and U' variables steps up the game, matching seasoned endoscopists with 86.30% accuracy.…
In a gastric cancer retrospective study, researchers classified tumor deposits into distinct types. Of 868 patients, 11.1% had tumor deposits, revealing poorer survival (3-year overall survival: 53.2%) compared to those without (87.0%). Irregular nodule and the tumor deposits complex showed the worst prognosis (3-year overall…
In the quest for optimal gastric cancer surgery, a study of 11,173 patients in the US compared robotic and laparoscopic gastrectomy. The analysis revealed that robotic gastrectomy (RG) outshone laparoscopic gastrectomy (LG) in terms of adequate lymphadenectomy, negative margins, shorter hospital stay, lower mortality, and…
In the era of widespread colonoscopy, many patients later diagnosed with esophageal adenocarcinoma (EA) had prior screening colonoscopies, presenting missed opportunities for earlier detection. Among 221 referred patients, 49% had prior colonoscopies, yet only 18% had an esophagogastroduodenoscopy (EGD) before EA diagnosis. Most displayed gastroesophageal…
Comparing neoadjuvant radiochemotherapy protocols for resectable esophageal cancer, this study finds no significant differences in postoperative mortality, complications, or toxicity. Both PF-based and CROSS protocols demonstrate effectiveness and safety, with squamous cell carcinoma and favorable tumor grading independently predicting a higher pathological complete response rate.…
In the quest for effective gastroenteropancreatic neuroendocrine carcinoma treatments, researchers unleashed patient-derived tumor spheroids. A dazzling 16 compounds, notably tyrosyl-DNA phosphodiesterase 1 inhibitors, emerged as fierce warriors against over 75% of these rare tumors. Cytarabine, a standout from the bunch, synergized with standard drugs, intensifying…
In exploring single-incision laparoscopic gastrectomy for early gastric cancer, researchers found it safe and feasible compared to multiport laparoscopy. Analyzing cases from 2013 to 2021, the single-incision approach showed similar operation times and length of stay. Complication rates were comparable, supporting the cautious adoption of…
In a nonrandomized trial comparing robotic gastrectomy with fluorescence guidance and a two-port system (IRG) to conventional laparoscopic gastrectomy (CLG) for early gastric cancer, researchers found that IRG yielded more retrieved lymph nodes (42.1 vs. 35.1). The study suggests that the integrated robotic approach enhances…
